SAR study on inhibitors of Hsp90α using machine learning methods

被引:1
作者
Zhang, Zhongyuan [1 ]
Tian, Yujia [1 ]
Yan, Aixia [1 ]
机构
[1] Beijing Univ Chem Technol, Dept Pharmaceut Engn, State Key Lab Chem Resource Engn, 15 BeiSanHuan East Rd,POB 53, Beijing 100029, Peoples R China
基金
中国国家自然科学基金;
关键词
Heat shock protein 90; Hsp90; inhibitors; Machine learning; Classify; Information gain; PROTEIN; 90; INHIBITORS; BIOLOGICAL EVALUATION; CLINICAL DEVELOPMENT; POTENT INHIBITORS; HSP90; PHASE-I; DERIVATIVES; DISCOVERY; DESIGN; COMBINATION;
D O I
10.1007/s42514-021-00084-7
中图分类号
TP3 [计算技术、计算机技术];
学科分类号
0812 ;
摘要
Heat shock protein 90 (Hsp90) is a promising target for cancer treatment, developing new effective Hsp90 inhibitors is of great significance in anticancer therapy. In this study, 20 machine learning models were constructed on 1321 molecules in order to precisely classify highly active and weakly active Hsp90 inhibitors. Six types of fingerprints including MACCS keys (MACCS), Extended connectivity fingerprints with radius 2 (ECFP_4), PubChem fingerprints, Estate fingerprints, Substructure fingerprints and 2D atom pairs fingerprints were applied to characterize Hsp90 inhibitors. Five machine learning algorithms containing support vector machine (SVM), decision tree (DT), random forest (RF), gradient boosting decision tree (GBDT) and multilayer perceptron (MLP) were utilized to develop classification models. The best RF and SVM models resulted in MCC values of 0.8070 and 0.8003, respectively. The fingerprints of these best models were analyzed by information gain (IG) method. Based on the IG analysis, we found some favorable substructures of highly active Hsp90 inhibitors. Moreover, we clustered 1321 Hsp90 inhibitors into eight subsets, further analyzed and summarized the structural characteristics of each subset. It was found that purine scaffold and resorcinol appeared frequently in highly active Hsp90 inhibitors.
引用
收藏
页码:353 / 364
页数:12
相关论文
共 39 条
  • [1] Prediction of new Hsp90 inhibitors based on 3,4-isoxazolediamide scaffold using QSAR study, molecular docking and molecular dynamic simulation
    Abbasi, Maryam
    Sadeghi-Aliabadi, Hojjat
    Amanlou, Massoud
    [J]. DARU-JOURNAL OF PHARMACEUTICAL SCIENCES, 2017, 25
  • [2] Discovery of new heat shock protein 90 inhibitors using virtual co-crystallized pharmacophore generation
    Al-Sha'er, Mahmoud A.
    Mansi, Iman
    Khanfar, Malak
    Abudayyh, Alaa
    [J]. JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY, 2016, 31 : 64 - 77
  • [3] Progress in the Discovery and Development of Heat Shock Protein 90 (Hsp90) Inhibitors
    Bhat, Rohit
    Tummalapalli, Sreedhar R.
    Rotella, David P.
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 2014, 57 (21) : 8718 - 8728
  • [4] Random forests
    Breiman, L
    [J]. MACHINE LEARNING, 2001, 45 (01) : 5 - 32
  • [5] A COMPARISON OF DECISION TREE CLASSIFIERS WITH BACKPROPAGATION NEURAL NETWORKS FOR MULTIMODAL CLASSIFICATION PROBLEMS
    BROWN, DE
    CORRUBLE, V
    PITTARD, CL
    [J]. PATTERN RECOGNITION, 1993, 26 (06) : 953 - 961
  • [6] The HSP90 inhibitor NVP-AUY922 inhibits growth of HER2 positive and trastuzumab-resistant breast cancer cells
    Canonici, Alexandra
    Qadir, Zulfiqar
    Conlon, Neil T.
    Collins, Denis M.
    O'Brien, Neil A.
    Walsh, Naomi
    Eustace, Alex J.
    O'Donovan, Norma
    Crown, John
    [J]. INVESTIGATIONAL NEW DRUGS, 2018, 36 (04) : 581 - 589
  • [7] A phase I/II study of KW-2478, an Hsp90 inhibitor, in combination with bortezomib in patients with relapsed/refractory multiple myeloma
    Cavenagh, J.
    Oakervee, H.
    Baetiong-Caguioa, P.
    Davies, F.
    Gharibo, M.
    Rabin, N.
    Kurman, M.
    Novak, B.
    Shiraishi, N.
    Nakashima, D.
    Akinaga, S.
    Yong, K.
    [J]. BRITISH JOURNAL OF CANCER, 2017, 117 (09) : 1295 - 1302
  • [8] CORTES C, 1995, MACH LEARN, V20, P273, DOI 10.1023/A:1022627411411
  • [9] Natural heat shock protein 90 inhibitors in cancer and inflammation
    Costa, Thadeu E. M. M.
    Raghavendra, Nulgumnalli Manjunathaiah
    Penido, Carmen
    [J]. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2020, 189
  • [10] NVP-AUY922: A novel heat shock protein 90 inhibitor active against xenograft tumor growth, angiogenesis, and metastasis
    Eccles, Suzanne A.
    Massey, Andy
    Raynaud, Florence I.
    Sharp, Swee Y.
    Box, Gary
    Valenti, Melanie
    Patterson, Lisa
    Brandon, Alexis de Haven
    Gowan, Sharon
    Boxall, Frances
    Aherne, Wynne
    Rowlands, Martin
    Hayes, Angela
    Martins, Vanessa
    Urban, Frederique
    Boxall, Kathy
    Prodromou, Chrisostomos
    Pearl, Laurence
    James, Karen
    Matthews, Thomas P.
    Cheung, Kwai-Ming
    Kalusa, Andrew
    Jones, Keith
    McDonald, Edward
    Barril, Xavier
    Brough, Paul A.
    Cansfield, Julie E.
    Dymock, Brian
    Drysdale, Martin J.
    Finch, Harry
    Howes, Rob
    Hubbard, Roderick E.
    Surgenor, Alan
    Webb, Paul
    Wood, Mike
    Wright, Lisa
    Workman, Paul
    [J]. CANCER RESEARCH, 2008, 68 (08) : 2850 - 2860